Plasma MIA, CRP, and Albumin Predict Cognitive Decline in Parkinson's Disease.
Junchao ShenNoor AmariRebecca ZackR Tyler SkrinakTravis L UngerMarijan PosaviThomas Francis TropeaSharon X XieVivianna M Van DeerlinRichard B DeweyDaniel WeintraubJohn Q TrojanowskiAlice S Chen-PlotkinPublished in: Annals of neurology (2022)
An easily obtained plasma-based predictor identifies individuals with PD at risk for cognitive decline. MIA may participate causally in development of cognitive decline. ANN NEUROL 2022;92:255-269.